David Lynn
CEO, Everest Healthcare Properties
David Lynn is CEO and Founder of Everest Healthcare Properties. Dr. Lynn has a long history of investing in real estate investments. Dr. Lynn has invested in over 220 transactions totaling over $20 billion over the course of his career. At Everest, he manages the overall firm’s activities including investment strategy, sourcing, research, acquisitions, underwriting, equity and debt financing, portfolio management, leasing, repositioning/value-add activities and financial reporting. Prior to founding Everest in 2014, Dr. Lynn was CIO and Executive Vice President at Cole Investments where he managed the firm’s $12.3 billion dollar investments including acquisitions and portfolio management of five real estate asset classes including MOBs, bioscience, and pharmaceutical buildings.
Prior to Cole, David was a Partner and Managing Director at ING Clarion Partners (ING was the world’s largest real estate asset manager at $130 billion in assets), where he was Head of Strategy, leading all the firm’s strategic and tactical investment decisions for the $45 billion portfolio. At ING Clarion, he led a programmatic joint venture with a leading medical group, developing state of the art MOBs throughout the southwest. He led the investment strategy to invest in biotech and bioscience buildings, investing and creating a portfolio of $300 million. He created and led the investment of senior housing, working with senior housing developers and developing over $430 million of Class A senior housing. Prior to ING Clarion, he was Head of Strategy for AIG Global Real Estate, where he led real estate investment strategy across five asset classes around the world including $150 million of regional medical centers. He was Head of international Investments for the Keppel Corporation (one of the largest property groups in Asia comprising a $43 billion portfolio) where he purchased and renovated over $1 billion of medical centers and hospitals around the Southeast Asia region.
Privcap Email Updates
Subscribe to receive email notifications whenever new talks are published.